Breast cancer can be divided into the molecular types—luminal A, luminal B, ERBB2+, and triple negative breast cancer (TNBC)—based on different expression profiles of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [10]. This evidence concerns the gene ERBB2 and breast carcinoma.